Reducing the immediate availability of red blood cells in cardiac surgery, a single-centre experience

Netherlands Heart Journal

Volumn 23, Issue 1, 2015, Pages 28-32

  Haanschoten, M C ^a   van Straten, A H M ^a   Verstappen, F ^a   van de Kerkhof, D ^a   van Zundert, A A J ^a,b,c   Soliman Hamad, M A ^a  

^a CATHARINA HOSPITAL   (Netherlands)

^b GHENT UNIVERSITY HOSPITAL   (Belgium)

^c MAASTRICHT UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Cardiac surgery; Red blood cells; Transfusion

Indexed keywords

HEMOGLOBIN;

ADULT; AGED; ARTICLE; BLOOD TRANSFUSION; CEREBROVASCULAR ACCIDENT; CHRONIC OBSTRUCTIVE LUNG DISEASE; CORONARY ARTERY BYPASS GRAFT; DIABETES MELLITUS; ERYTHROCYTE; EUROSCORE; FEMALE; HEALTH CARE AVAILABILITY; HEALTH CARE POLICY; HEART ATRIUM FIBRILLATION; HEART INFARCTION; HEART LEFT VENTRICLE EJECTION FRACTION; HEART SURGERY; HEART VALVE SURGERY; HOSPITALIZATION; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PERIPHERAL VASCULAR DISEASE; POSTOPERATIVE HEMORRHAGE; POSTOPERATIVE PERIOD; SEVERE RENAL IMPAIRMENT; SURGICAL INFECTION; VERY ELDERLY;

EID: 84918828602     PISSN: 15685888     EISSN: 18766250     Source Type: Journal    
DOI: 10.1007/s12471-014-0618-9     Document Type: Article

References (21)

1. Murphy GJ, Reeves BC, Rogers CA, et al. Increased mortality, postoperative morbidity, and cost after red blood cell transfusion in patients having cardiac surgery. Circulation. 2007;116(22):2544–52.
2. van Straten AH, Bekker MW, Soliman Hamad MA, et al. Transfusion of red blood cells: the impact on short-term and long-term survival after coronary artery bypass grafting, a ten-year follow-up. Interact Cardiovasc Thorac Surg. 2010;10(1):37–42.
3. Koch CG, Li L, Duncan AI, et al. Morbidity and mortality risk associated with red blood cell and blood-component transfusion in isolated coronary artery bypass grafting. Crit Care Med. 2006;34:1608–16.
4. van Straten AH, Kats S, Bekker MW, et al. Risk factors for red blood cell transfusion after coronary artery bypass graft surgery. J Cardiothorac Vasc Anesth. 2010;24:413–7.
5. van Straten AH, Soliman Hamad MA, van Zundert AA. Martens EJ, ter Woorst JF, de Wolf AMEffect of duration of red blood cell storage on early and late mortality after coronary artery bypass grafting. J Thorac Cardiovasc Surg. 2011;141(1):231–7.
6. Koch CG, Li L, Sessler DI, et al. Duration of red-cell storage and complications after cardiac surgery. N Engl J Med. 2008;20(358): 1229–39.
7. Basran S, Frumento RJ, Cohen A, et al. The association between duration of storage of transfused red blood cells and morbidity and mortality after reoperative cardiac surgery. Anesth Analg. 2006;103: 15–20.
8. Van deWatering L, Lorinser J, Versteegh M, et al. Effects of storage time of red blood cell transfusions on the prognosis of coronary artery bypass graft patients. Transfusion. 2006;46:1712–8.
9. McKenny M, Ryan T, Tate H, et al. Age of transfused blood is not associated with increased postoperative adverse outcome after cardiac surgery. Br J Anaesth. 2011;106:643–9.
10. Sanders J, Patel S, Cooper J, et al. Red blood cell storage is associated with length of stay and renal complications after cardiac surgery. Transfusion. 2011;51(11):2286–94.
11. Koch CG, Li L, Duncan AI, et al. Transfusion in coronary artery bypass grafting is associated with reduced long-term survival. Ann Thorac Surg. 2006;81(5):1650–7.
12. Zimrin AB, Hess JR. Current issues relating to the transfusion of stored red blood cells. Vox Sang. 2009;96(2):93–103.
13. Dzik W. Fresh blood for everyone? Balancing availability and quality of stored RBCs. Transfus Med. 2008;18(4):260–5.
14. Hod EA, Brittenham GM, Billote GB, et al. Transfusion of human volunteers with older, stored red blood cells produces extravascular hemolysis and circulating non-transferrin-bound iron. Blood. 2011;118(25):6675–82.
15. Tinmouth A, Fergusson D, Yee IC, et al. Clinical consequences of red cell storage in the critically ill. Transfusion. 2006;46(11):2014–27.
16. Beckmann SR, Carlile D, Bissinger RC, et al. Improved coagulation and blood conservation in the golden hours after cardiopulmonary bypass. J Extra Corp Technol. 2007;39:103–8.
17. Takagi H, Manabe H, Kawai N, et al. Aprotinin increasesmortality as compared with tranexamic acid in cardiac surgery: a meta-analysis of randomized head-to-head trials. Interact Cardiovasc Thorac Surg. 2009;9:98–101.
18. Raghunathan K, Connelly NR, Kanter GJ. ε-Aminocaproic acid and clinical value in cardiac anesthesia. J Cardiothorac Vasc Anesth. 2011;25:16–9.
19. Likosky DS, FitzGerald DC, Groom RC, et al. The effect of the perioperative blood transfusion and blood conservation in cardiac surgery Clinical Practice Guidelines of the Society of Thoracic Surgeons and the Society of Cardiovascular Anesthesiologists upon clinical practices. J Extra Corp Technol. 2010;42:114–21.
20. Moskowitz DM, McCullough JN, Shander A, et al. The impact of blood conservation on outcomes in cardiac surgery: is it safe and effective? Ann Thorac Surg. 2010;90:451–8.
21. Wang G, Bainbridge D, Martin J, et al. The efficacy of an intraoperative cell saver during cardiac surgery: a meta-analysis of randomized trials. Anesth Analg. 2009;109:320–30.